Cargando…

Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population

Study has demonstrated that TNIP1 polymorphisms are associated with an increased risk of HBV-induced hepatocellular carcinoma (HCC). The purpose of this study was to investigate the correlation between polymorphisms in TNIP1 and HCC risk in a Northwest Chinese Han population. A case–control study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yuting, Zhang, Lihua, Bao, Yang, Wu, Pengfei, Zhang, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545217/ https://www.ncbi.nlm.nih.gov/pubmed/33761643 http://dx.doi.org/10.1097/MD.0000000000024843

Ejemplares similares

Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma
por: Liu, Zhao, et al.
Publicado: (2016)

Hyperlipoproteinemia (a) is associated with breast cancer in a Han Chinese population
por: Xu, Jing, et al.
Publicado: (2020)

Relationship between the TERT, TNIP1 and OBFC1 genetic polymorphisms and susceptibility to colorectal cancer in Chinese Han population
por: Li, Chuang, et al.
Publicado: (2017)

Association of a TNIP1 Polymorphism with Vogt-Koyanagi-Harada Syndrome but Not with Ocular Behcet’s Disease in Han Chinese
por: Shi, Yanyun, et al.
Publicado: (2014)

Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population
por: Zhao, Lisha, et al.
Publicado: (2020)

Impact of CCL4 gene polymorphisms upon the progression of lung cancer in a Han Chinese cohort
por: Hu, Weiwei, et al.
Publicado: (2020)

IMPA2 polymorphisms and risk of ischemic stroke in a northwest Han Chinese population
por: Ma, Qiaoya, et al.
Publicado: (2016)

Association between TNIP1, MPHOSPH6 and ZNF208 genetic polymorphisms and the coronary artery disease risk in Chinese Han population
por: Song, Yanbin, et al.
Publicado: (2017)

Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis
por: Wang, Qinjing, et al.
Publicado: (2022)

Combined low miRNA-29s is an independent risk factor in predicting prognosis of patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study
por: Zhang, Zhen, et al.
Publicado: (2017)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: Case-control study
por: Li, Yanqiu, et al.
Publicado: (2016)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

Mutation differences in circulating tumor DNAs from non-small cell lung cancer patients between Uygur and Han populations
por: Wang, Yuli, et al.
Publicado: (2021)

Impact of tenofovir antiviral treatment on survival of chronic hepatitis B related hepatocellular carcinoma after hepatectomy in Chinese individuals from Qingdao municipality
por: Ge, Zhong, et al.
Publicado: (2020)

Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival
por: Yu, Xiaoteng, et al.
Publicado: (2015)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells
por: Guo, Zhe, et al.
Publicado: (2015)

Bulbar Paralysis and Facial Paralysis due to Metastatic Hepatocellular Carcinoma: A Case Report and Literature Review
por: Liu, Min, et al.
Publicado: (2016)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017)

Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis
por: Zhang, Mingwei, et al.
Publicado: (2016)

Hot food and beverage consumption and the risk of esophageal squamous cell carcinoma: A case-control study in a northwest area in China
por: Tai, Wei-Ping, et al.
Publicado: (2017)

Contribution of PNPLA3 gene polymorphisms to hepatocellular carcinoma susceptibility in the Chinese Han population
por: Gong, Dongwei, et al.
Publicado: (2022)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients
por: Wu, Li-Li, et al.
Publicado: (2016)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Li, Jinpeng, et al.
Publicado: (2021)

The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017)

Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis
por: He, Bosheng, et al.
Publicado: (2017)

The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies
por: Han, Cuihong, et al.
Publicado: (2017)

Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction
por: Tu, Haibin, et al.
Publicado: (2023)

Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Shi, Xinhui, et al.
Publicado: (2021)

Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis
por: Xian, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02avp9vopmg3ifn25iesu9v9k3